Doctor profile · Federal record
Dr. Rachel Delost, DO
Dermatology Physician (CMS: Dermatology) · Warren, OH
- NPI 1659861839
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2223 Niles Cortland RD Se
Warren, OH 444843043
(330) 965-8760
fax (330) 469-9706 - Mailing address
-
111 New Hampshire Ave Ste 2
Portsmouth, NH 038012864
Credentials & registration
- NPI registered
- May 2018 — 8 yrs on file
- Profile last updated
- January 31, 2024
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #34.015757
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659861839. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
605
Distinct HCPCS
10
Medicare allowed
$49,137
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 103 | 30 | $6 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 85 | 85 | $106 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 80 | 45 | $119 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 79 | 79 | $158 | |
17000 |
Destruction of precancer skin growth, 1 growth | 50 | 45 | $49 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 42 | 38 | $84 | |
17110 |
Destruction of skin growth, 1-14 growths | 40 | 34 | $93 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | 13 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 22 | 20 | $54 | |
11104 |
Punch biopsy, first skin growth | 18 | 16 | $118 |
In context: peer comparison
Among 1 peers in Warren Dermatology Physician, average services per provider: 43. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$2,348
Transactions
103
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 43 | $614.94 | |
| Incyte Corporation | 7 | $430.53 | |
| Genzyme Corporation | 7 | $318.31 | |
| Abbvie INC. | 15 | $254.74 | |
| Dermavant Sciences, INC. | 4 | $96.95 | |
| Novartis Pharmaceuticals Corporation | 4 | $83.25 | |
| Pfizer INC. | 5 | $73.14 | |
| Leo Pharma INC. | 3 | $70.00 | |
| Lilly USA, LLC | 3 | $69.33 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $66.76 | |
| Ucb, INC. | 2 | $50.88 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 2 | $47.64 | |
| Sun Pharmaceutical Industries INC. | 2 | $39.26 | |
| Galderma Laboratories, L.P. | 2 | $35.40 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $31.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
347
Patients
220
Total drug cost
$11,417
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 89 | 63 | $1,230 |
| Ketoconazole | Generic | 84 | 56 | $2,451 |
| Clobetasol Propionate | Generic | 61 | 41 | $4,425 |
| Prednisone | Generic | 26 | 15 | $198 |
| Hydrocortisone | Generic | 25 | 19 | $127 |
| Doxycycline Hyclate | Generic | 17 | 11 | $326 |
| Fluorouracil | Generic | 17 | 15 | $1,599 |
| Clindamycin Phosphate | Generic | 15 | 0 | $974 |
| Mupirocin | Generic | 13 | 0 | $85 |
Frequently asked questions
What is Dr. Rachel Delost's medical specialty?
Dr. Rachel Delost practices Dermatology Physician in Warren, OH.
Where does Dr. Rachel Delost practice?
Dr. Rachel Delost practices at 2223 Niles Cortland RD Se, Warren, OH 444843043. Office phone: 3309658760.
What is Dr. Rachel Delost's NPI?
Dr. Rachel Delost's National Provider Identifier (NPI) is 1659861839, issued by NPPES.
Does Dr. Rachel Delost accept Medicare assignment?
Yes. Dr. Rachel Delost accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Delost commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); New patient office or other outpatient visit (HCPCS 99203); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.